Abstract:Objective To investigate the molecule mechanism of microRNA (miR)-138 in inhibiting invasion and migration of breast cancer by regulating epithelial mesenchymal transformation (EMT). Methods Reverse transcription-polymerase chain reaction (RT-PCR) was used to detect expression of miR-138 after transfecting miR negative control simulacrum (miR-NC) and miR-138 simulacrum in human normal mammary epithelial cell (MCF-10A) and breast cancer cells (MCF-7 and MDA-MB-231) from July 2017 to June 2018. MTT method was used to detect the breast cancer cell activity. Cell scratch test and Transwell test were used to detect the breast cancer cell migration distance and invasion rate. RT-PCR was used to detect the expression of the EMT key molecules Vimentin, N-cadherin and E-cadherin after transfecting miR-138 simulacrum. Results The expression level of miR-138 in MCF-10A was significantly higher than that in MCF-7 and MDA-MB-231 (1.006 ± 0.009 vs. 0.324 ± 0.027 and 0.512 ± 0.068), and there was statistical difference (P＜0.05); there was no statistical difference in the expression level of miR-138 between MCF-7 and MDA-MB-231 (P＞0.05). The breast cancer cell viabilities of MCF-7 and MDA-MB-231 at third and fourth day after transfecting miR-138 simulacrum were significantly lower than those of transfecting miR-NC (MCF-7: 0.514 ± 0.052 vs. 0.593 ± 0.061 and 0.643 ± 0.074 vs. 0.784 ± 0.081; MDA-MB-231: 0.552 ± 0.043 vs. 0.614 ± 0.063 and 0.673 ± 0.074 vs. 0.792 ± 0.077), and there were statistical differences (P＜0.05). The breast cancer cell migration distances and invasion rates of MCF-7 and MDA-MB-231 after transfecting miR-138 simulacrum were significantly lower than those of transfecting miR-NC (MCF-7: 0.572 ± 0.051 vs. 1.003 ± 0.012 and 0.624 ± 0.043 vs. 1.002 ± 0.007, MDA-MB-231: 0.472 ± 0.051 vs. 1.003 ± 0.095 and 0.573 ± 0.044 vs. 1.004 ± 0.091), and there were statistical differences (P＜0.05). The expressions of Vimentin and N-cadherin mRNA in MCF-7 and MDA-MB-231 after transfecting miR-138 simulacrum were significantly lower than those of transfecting miR-NC, but the expression of E-cadherin mRNA was significantly increased, and there were statistical differences (P＜0.05). Conclusions The expressions of miR-138 in both breast cancer cells decreased. Overexpression of miR-138 in breast cancer cell can inhibit proliferation, migration and invasion via regulating EMT.

Mir-125A-5p Suppresses Epithelial-Mesenchymal Transition Via GSK-3β/Snail Signaling Pathway in Breast Cancer Cells

Mir-145 Suppresses Breast Cancer Cell Migration by Targeting FSCN-1 and Inhibiting Epithelial-Mesenchymal Transition.

MiR-30 Suppresses Lung Cancer Cell 95D Epithelial Mesenchymal Transition and Invasion Through Targeted Regulating Snail.

Mir-125A-5p Inhibits the Migration of Breast Cancer Cells by Targeting GAB2

Mir-124 Targets Slug to Regulate Epithelial-Mesenchymal Transition and Metastasis of Breast Cancer

Mir-145-5p Inhibits Epithelial-Mesenchymal Transition Via the JNK Signaling Pathway by Targeting MAP3K1 in Non-Small Cell Lung Cancer Cells.

The Mirna125a-5P and Mirna125b-1-5p Cluster Induces Cell Invasion by Down-Regulating DDB2-reduced Epithelial-to- Mesenchymal Transition (EMT) in Colorectal Cancer

MiR-125b regulates the proliferation and metastasis of triple negative breast cancer cells via the Wnt/β-catenin pathway and EMT

Mir-129-5p Attenuates Cell Proliferation and Epithelial Mesenchymal Transition Via HMGB1 in Gastric Cancer

miR-615-3p promotes the epithelial-mesenchymal transition and metastasis of breast cancer by targeting PICK1/TGFBRI axis

Inhibition of Migration and Invasion of Gastric Cancer Cells by Snail-Regulated Mir-375 Through Jak2 Targeting

Mir-125B is Methylated and Functions As a Tumor Suppressor by Regulating the ETS1 Proto-Oncogene in Human Invasive Breast Cancer.

Mir-93-5p Inhibits the Emt of Breast Cancer Cells Via Targeting Mkl-1 and Stat3

Data from Mir-125B is Methylated and Functions As a Tumor Suppressor by Regulating the ETS1 Proto-oncogene in Human Invasive Breast Cancer

MiR-125 inhibited cervical cancer progression by regulating VEGF and PI3K/AKT signaling pathway

Mir-503-3p Promotes Epithelialemesenchymal Transition in Breast Cancer by Directly Targeting Smad2 and E-Cadherin

Mechanism of Microrna-138 in Inhibiting Invasion and Migration of Breast Cancer by Regulating Epithelial Mesenchymal Transformation

Mir‑185‑5p Inhibits F‑actin Polymerization and Reverses Epithelial Mesenchymal Transition of Human Breast Cancer Cells by Modulating RAGE.

Mir-125a-3p Inhibits Er Alpha Transactivation And Overrides Tamoxifen Resistance By Targeting Cdk3 In Estrogen Receptor-Positive Breast Cancer

MiR-125b regulates epithelial-mesenchymal transition via targeting Sema4C in paclitaxel-resistant breast cancer cells.

Mir-34b Inhibits Breast Cancer Cell Epithelial-Mesenchymal Transition (Emt) And Invasion Via Targeting Glioma-Associated Oncogene Protein 1 (Gli1)